Different glomerular diseases have been reported in people with COVID-19 and/or after vaccination against SARS-CoV-2, with the development of collapsing FSGS being observed more frequently in populations with high-risk APOL1 genotypes. However, a causal link between glomerular diseases and COVID-19 infection or its vaccine is not firmly established. To evaluate the real impact of the COVID-19 pandemic on the epidemiology of glomerular diseases, we conducted a retrospective multicenter study analyzing the clinical manifestations and histological findings in renal biopsies during the pre-pandemic and pandemic period.
No takes yet. Share an insight, caveat, or question.
Valjalo et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: